CAS 1648843-04-2

(2-(((5-((4-Fluorophenyl)carbamoyl)pyrimidin-2-yl)thio)methyl)-4-(trifluoromethoxy)phenyl)boronic acid

CAS: 1648843-04-2

Formel: C₁₉H₁₄BF₄N₃O₄S

Reinheit: %

Farbe und Form: Solid

Molekulargewicht: 467.2018

Ref: IN-DA01KL1H

(2-(((5-((4-Fluorophenyl)Carbamoyl)Pyrimidin-2-Yl)Thio)Methyl)-4-(Trifluoromethoxy)Phenyl)Boronic Acid

CAS: 1648843-04-2

(2-(((5-((4-Fluorophenyl)Carbamoyl)Pyrimidin-2-Yl)Thio)Methyl)-4-(Trifluoromethoxy)Phenyl)Boronic Acid

Reinheit: 98+%

Molekulargewicht: 467.2g/mol

Ref: 54-PC108580

SX-682

CAS: 1648843-04-2

SX-682

Reinheit: ≥98%

Molekulargewicht: 467.2g/mol

Ref: 54-BUP12904

SX-682

CAS: 1648843-04-2

SX-682 is an orally available allosteric inhibitor of CXCR1 and CXCR2.Cost-effective and quality-assured.

Formel: C₁₉H₁₄BF₄N₃O₄S

Reinheit: 98.19% - 99.61%

Farbe und Form: Solid

Molekulargewicht: 467.2

Ref: TM-T8497

SX-682

CAS: 1648843-04-2

SX-682 is an orally bioavailable antagonist of the chemokine receptor CCR1, which is derived from advanced medicinal chemistry efforts targeting inflammatory pathways. Its mode of action involves selectively blocking the interaction between CCR1 and its ligands, thereby inhibiting the recruitment and activation of immune cells such as monocytes and macrophages. This action modulates inflammatory responses and has shown promise in dampening pathological inflammation.

Formel: C₁₉H₁₄BF₄N₃O₄S

Reinheit: Min. 95%

Molekulargewicht: 467.2 g/mol

Ref: 3D-YQC84304